Trim 40-50% of GS allocation staged 60/40 into $917-$952 resistance; residual capped at 50-60% benchmark weight with lower Bollinger band stop
The calibration synthesis resolves the disagreement among the three analysts by adopting the trader's 40-50% trim magnitude and the neutral analyst's 60/40 staging structure, but tightening the residual cap from 65% to 50-60% per the 9/30 reflection and tightening the stop from the neutral's $970-980 to the lower Bollinger band at $858.68 per the Research Manager's plan. The decision explicitly rejects: (1) aggressive analyst's full-conviction single-shot short with $1,000 stop, (2) conservative analyst's 5-10pp trim and "wait for confirmation," (3) neutral analyst's $970-980 stop and 65% residual cap, (4) pure Hold without trim, (5) full Sell (violates 9/24 buyback-floor lesson given $122.7B equity cushion and $4.68B/quarter buybacks), and (6) covered-call overlay or vol-selling as primary expression. GS at $900 with $4.68B/quarter buybacks and $122.7B equity cushion is not a full-exit candidate, but the technical breakdown (price $51 below broken 200 SMA, MACD at lowest reading in visible window, 30-session lower-high/lower-low sequence) materially exceeds the 9/25 escalation threshold, making a 40-50% trim the correct expression.
| Position | Action |
|---|---|
| Price approaches $917-$952 resistance band | Scale in (trim) 40-50% of target allocation, staged 60/40 over 2-3 trading sessions |
| Residual position exceeds 50-60% of benchmark weight | Cease adding; enforce position ceiling |
| Daily close below $858.68 on expansion volume | Hard stop on residual position |
| Weekly close below $850 | Full-exit escalation |
| Q3 print <$17 OR credit-related provisions OR stock closes below $940 on print day | Escalate toward Sell; exit residual entirely |
| Q3 print beats consensus by >5% EPS AND stock holds $952 through print | Reassess to Overweight; restore toward full weight on $1,012 reclaim |
| Q3 print in-line ($17-19) with no guidance change | Maintain Underweight; reassess post-November |
| Q3 print with constructive guidance AND stock reclaims $952 | Upgrade to Hold first, then Overweight on follow-through |
Fundamentals are dramatically mispricing GS — Q2 EPS nearly doubled YoY, the stock trades at a 34% P/E discount to the S&P 500, and the company returns ~9.6% of market cap annually while RSI sits near oversold at 30.46.
| Indicator | Value | Signal |
|---|---|---|
| close_10_ema | 917.43 | bearish |
| close_50_sma | 997.80 | bearish |
| close_200_sma | 952.28 | bearish |
| macd | -31.93 | bearish |
| macd_signal | -27.87 | bearish |
| macd_histogram | -4.06 | bearish |
| rsi | 30.46 | bearish |
| boll_ub | 1045.45 | neutral |
| boll_mb | 952.02 | neutral |
| boll_lb | 858.68 | bearish |
| atr | 23.49 |
This report is AI-generated for informational and educational purposes only and is not investment advice or a recommendation to buy or sell any security. Full disclaimer.
When: Confirmed daily close above $952 on >3.5M shares with MACD histogram turning positive
Then: Disciplined mean-reversion reclaim signal; reassess to Overweight
↩ rebuts: “Bear argument that no narrative is bearish; absence of negative news with strong execution is structurally bullish”
· concedes: Technical setup is ugly — price below all major moving averages, MACD deeply negative, VWMA confirms selling, pattern of lower highs and lower lows is textbook bearish; Stock is down 15% from its August peak; Bear's 'no narrative' observation is acknowledged, though argued to be bullish (no negative catalyst present); Stagflation fears and M&A market concerns have some validity, though mega-cap strategic activity is argued to be independent of small-cap directionlessness
GS is at a cyclical peak with peak earnings that will mean-revert, a "discount" that is actually the market correctly pricing that mean reversion, buyback support that disappears under stress, and a late-cycle balance sheet expansion that historically precedes 30–50% drawdowns in bank stocks.
EV: -10% to -20% (target $750-$800 over 6 months from ~$893) · concedes: Q2 2026 results were genuinely strong (+39.5% YoY revenue, +92% YoY EPS); GS does have a strong franchise and diversification across investment banking, trading, and advisory; Buybacks do return capital to shareholders in non-stress regimes; The 13.8x P/E is below GS's historical average and below the S&P 500 multiple; FICC can be a strong revenue driver in genuinely two-sided vol environments
→ vs conservative: The 'hold' recommendation will result in watching the 858 level break then chasing a worse entry; valuation cushion (12.3x P/E) is a trap as the multiple can compress to 9x in cyclical reset despite current peak earnings
→ vs neutral: Waiting for breakdown below 858 to confirm shorts means buying 8-10% higher; waiting for confirmation destroys the risk-reward asymmetry; overhead supply becomes the entry point, not a signal to wait
→ vs conservative: RSI at 30.46 is not a mean reversion buy signal; in sustained downtrends RSI can sit at or below 30 for weeks; no bullish divergence exists (no higher low in RSI while price makes lower low)
| vwma | 929.53 | bearish |
Support: 886.88 · 858.68 · 830 · 850 | Resistance: 917.43 · 952.02 · 952.28 · 997.8 · 1045.45
GS trades at 893.46, down 15.2% from its August peak of 1053.72, with price below all three moving averages confirming a fully bearish alignment. MACD at -31.93 shows deepening negative momentum with no bullish crossover or divergence in sight, while the VWMA at 929.53 has fallen from ~1040 in early August, confirming broad volume participation in the selloff. Although RSI near 30.46 suggests oversold conditions and Bollinger lower band proximity (~858.68) could trigger tactical bounces, the path of least resistance remains lower until price recaptures the 10 EMA (917.43) or better. The report recommends HOLD and advises against initiating new longs; short positions have trend on their side with stops suggested near 847 using ATR-based sizing.
Market Cap
$260.15 billion
Outstanding Shares (Diluted)
~304.9 million
Stock Price (Implied)
~$853
52-Week High
$1,153.99
52-Week Low
$740.01
50-Day Moving Average
$1,003.78
200-Day Moving Average
$959.71
P/E (TTM)
13.80
Forward P/E
12.30
PEG Ratio
1.12
Price/Book
2.47
Dividend Yield
2.22%
Book Value per Share
$362.05
Q2 2026 Revenue
$20.34B
Q2 2026 Net Income
$6.63B
Q2 2026 Diluted EPS
$20.98
Q2 2026 Pretax Income
$8.56B
Q2 2026 Net Interest Income
$3.95B
Q2 2026 Interest Income
$22.05B
Q2 2026 Compensation
$6.10B
Q2 2026 Tax Rate
22.6%
TTM Revenue
$67.57B
TTM Net Income
$19.98B
TTM EPS
$64.75
TTM Profit Margin
31.04%
Operating Margin
42.18%
Q2 2026 Total Assets
$2,127.7B
Q2 2026 Total Liabilities
$2,005.0B
Q2 2026 Total Equity
$122.7B
Q2 2026 Common Stock Equity
$109.7B
Q2 2026 Tangible Book Value
$100.4B
Q2 2026 Total Debt
$475.0B
Q2 2026 Cash & Equivalents
$187.3B
Q2 2026 Net Debt
$285.7B
Q2 2026 Trading Securities
$538.6B
Q2 2026 Available-for-Sale Securities
$173.6B
Q2 2026 Receivables
$250.3B
Q2 2026 Net Loans
$260.9B
Current Ratio
1.563
Q2 2026 Investments & Advances
$794.2B
Q2 2026 Derivative Liabilities
$99.97B
Q2 2026 Goodwill
$7.3B
Q2 2026 Treasury Stock
$130.0B
ROE
16.9%
ROA
1.07%
Net Margin
31.0%
Operating Margin
42.2%
Comp Ratio
~30%
Total Capitalization
$482.3B
Preferred Stock Equity
$13.0B
Common Stock Equity
$109.7B
Preferred Shares
91,998,000
Treasury Shares
~640.8M
Debt-to-Equity (book)
7.7x
Q2 2026 Operating CF
+$6.11B
Q2 2026 Investing CF
-$28.57B
Q2 2026 Financing CF
+$30.92B
Q2 2026 Free Cash Flow
+$5.60B
Q2 2026 CapEx
-$502M
Q2 2026 Dividends Paid
-$1.60B
Q2 2026 Stock Buybacks
-$4.68B
Q2 2026 Net Debt Issuance
+$39.55B
Q2 2026 M&A Activity
$1.42B
Q2 2026 Total Capital Return
$6.28B
Beta
1.284
YoY Revenue Growth (Q2)
+39.5%
YoY EPS Growth (Q2)
+92.3%
Diluted Share Count Change
318.3M → 304.9M
Strengths
Concerns
Goldman Sachs demonstrated exceptional Q2 2026 performance with revenue of $20.34B (+39.5% YoY) and EPS of $20.98 (nearly doubled from $10.91), driven by robust investment banking activity, capital markets recovery, and trading strength. The balance sheet expanded 19% YoY to $2.13 trillion in assets, while the firm returned $6.28B to shareholders through dividends and buybacks. Despite strong fundamentals and a reasonable forward P/E of 12.3x, the stock trades ~26% below its 52-week high with bearish technical positioning (below both 50-DMA and 200-DMA), reflecting market concerns about the durability of this cyclical recovery given elevated leverage, regulatory risks, and inherent capital markets cyclicality.
Macro: Goldman Sachs faces a complex macro backdrop entering Q4 2026: the Fed has been sharply repriced toward a higher-for-longer stance with 96% probability of zero cuts in 2026 and a 20% probability of a 25 bps hike at the October 2026 meeting. Labor market weakness is being interpreted as stagflation-lite rather than a catalyst for easing. Equity markets show bifurcated internals with Nasdaq at fresh highs but the Dow slipping and small caps directionless, while commodities show a defensive bid in gold and silver. The market is not pricing imminent recession (US 8%, UK 7%, Japan 4%), but Jeffrey Gundlach's 'hollow tree' warning signals elevated tail risk for equity valuations. No company-specific GS news in the past two weeks means the stock is currently a pure macro proxy.